UBS Group set a €52.50 ($61.05) target price on Brenntag (FRA:BNR) in a research report report published on Monday, February 4th, www.boersen-zeitung.de reports. The firm currently has a buy rating on the stock.
BNR has been the subject of a number of other reports. Kepler Capital Markets set a €63.00 ($73.26) price objective on shares of Brenntag and gave the company a buy rating in a research note on Wednesday, November 7th. JPMorgan Chase & Co. set a €50.00 ($58.14) price objective on shares of Brenntag and gave the company a buy rating in a research note on Wednesday, November 28th. Commerzbank set a €61.00 ($70.93) price target on shares of Brenntag and gave the stock a buy rating in a research report on Wednesday, November 7th. Jefferies Financial Group set a €42.00 ($48.84) price target on shares of Brenntag and gave the stock a neutral rating in a research report on Thursday, December 27th. Finally, equinet set a €59.80 ($69.53) price target on shares of Brenntag and gave the stock a buy rating in a research report on Wednesday, November 7th. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average target price of €52.83 ($61.43).
BNR traded up €0.66 ($0.77) on Monday, reaching €44.26 ($51.47). The company had a trading volume of 364,755 shares. Brenntag has a one year low of €43.06 ($50.07) and a one year high of €56.25 ($65.41).
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
See Also: What is a stock buyback?
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.